甲状腺关联轨道病的眼外肌肉炎症活动的评估由[68Ga]DOTATATE PET/CTCT
Zhengquan Hu1,2, Jinyan Liu1, Haoyu Deng1
1Department of Nuclear Medicine (PET Center), Key Laboratory of Biological Nanotechnology of National Health Commission, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan, 410000, China.
Molecular imaging and biology
|January 14, 2025
概括
[68Ga]DOTATATE PET/CT有效评估甲状腺相关眼科医症 (TAO) 的眼外肌炎症. 这种成像技术显示出高精度和与其他方法的一致性,有助于对TAO患者进行精确的诊断和治疗规划.
科学领域:
- 核医学成像技术 核医学成像技术
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
背景情况:
- 甲状腺相关的眼病 (TAO) 涉及眼外肌肉 (EOM) 的炎症,需要准确的治疗评估.
- 目前用于评估TAO中EOM炎症的方法存在局限性.
研究的目的:
- 为了探索[68Ga]DOTATATE PET/CT在评估TAO患者中EOM炎症活动中的有效性.
- 将PET/CT检测结果与其他成像方法和临床结果进行比较.
主要方法:
- 在22名TAO患者和6名健康志愿者身上进行了轨道[68Ga]DOTATATE PET/CT.
- 对比分析包括[99mTc]DTPA SPECT/CT (18名患者) 和轨道MRI (4名患者).
- 在成像后对患者的治疗方案和预后进行了跟踪.
主要成果:
- [68 Ga]DOTATATE PET/CT准确评估了TAO中的EOM炎症活性,显示了与[99m Tc]DTPA SPECT/CT和MRI的高度一致性.
- 该技术为区分EOM和周围结构提供了更高的分辨率.
- 中间直肠肌肉的参与率最高 (AUC=0.976). 与症状治疗组相比,服用葡萄糖皮质激素的患者在EOM中SUVmax较高.
结论:
- [68Ga]DOTATATE PET/CT是一种可靠的成像方法,用于评估TAO中EOM炎症.
- 它提供了客观证据,支持TAO的精确诊断和治疗策略.
- 这种技术可以增强患有甲状腺相关眼科医症的患者的管理.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...


